University Of Pittsburgh

PHILADELPHIA — Midlife women with persistently poor sleep are at elevated risk for CV events, particularly when they experience insomnia and sleep no longer than 5 hours per night, according to study data.

Following last year’s U.S. Supreme Court’s decision overturning federal abortion protections, rheumatologists must change their practice with regard managing patients’ reproductive health, said presenter at the 2023 AWIR annual conference.

Rheumatologists can help patients with lupus and other rheumatic diseases avoid potentially dangerous unintended pregnancies by regularly documenting their contraception use, according to a presenter at the 2023 AWIR annual conference.

Researchers found a lower prevalence of statin use for primary and secondary atherosclerotic CVD prevention among nonwhite and female patients, which they said may be partially due to factors such as bias and stereotyping.

CHICAGO — Adjuvant pembrolizumab showed durable benefit vs. placebo among patients with resected stage IIB or IIC melanoma, according to randomized phase 3 study results presented at ASCO Annual Meeting.

During the transition to menopause many women may experience adverse changes to multiple cardiovascular risk factors, according to a North American Menopause Society Practice Pearl published in Menopause.

Polymyalgia rheumatica and giant cell arteritis can overlap and resemble one another in diagnosis and disease course, and understanding where one ends and the other begins is critical for rheumatologists and primary care providers alike.

Medical drama television episodes with narratives about e-cigarette- or vaping-associated lung injury — or EVALI — garnered more than 600 reactions from viewers on Twitter, according to a study published in Journal of Health Communication.

Black women had a greater probability of undergoing urine toxicology testing at delivery compared with other racial groups regardless of substance use history, researchers reported in JAMA Health Forum.

Losing eligibility for Medicaid supplemental insurance was linked to worse health care outcomes for people from underrepresented racial and ethnic populations, according to researchers.